Brain/ Mental Health
Study: Cognitively stimulating jobs help us maintain brain health as we age, delaying the onset of cognitive impairment and dementia
Workplace learning could be a boon for wellness, research shows (HR DIVE): Learning and development in the workplace could be a boon for wellness, new research suggests. Doing cognitively demanding work can delay the onset of brain decline and even dementia at an older age, according to the study published April 17 in the journal Neurology.…
Read MoreNew offering to refresh & enhance workplace Mental Health and Talent programs: Brain Health At Work
Does this sound familiar? Rush and multitasking everywhere, yet we’re seeing low productivity and high burnout because we’re not taking good care of our brain’s health. People aren’t really connecting with the old-school, medical ways of tackling Mental Health that just focus on what’s wrong. Employees are often wary of taking on new demanding tasks,…
Read MoreNew book encourages readers to embrace uncertainty in order to improve decision-making, mental health, and more
Life is uncertain. We never know what will happen, and many things are unknowable. This can make us feel stressed or worried, since the unknown is associated with danger. But as journalist Maggie Jackson argues in her new book, Uncertain: The Wisdom and Wonder of Being Unsure, there are many benefits to allowing ourselves to…
Read MoreExecutive Functions and Dysfunction in Brain Health and Brain Disorders: Dates announced for Dr. Elkhonon Goldberg’s Symposium in Costa Rica
We are pleased to announce a fantastic 5‑day professional development opportunity featuring our Advisor and renowned author and neuropsychologist Elkhonon Goldberg, Ph.D., ABPP., and titled “Executive Functions and Dysfunction in Brain Health and Brain Disorders. Frontal Lobes, Distributed Networks, and the Whole Brain.” The information presented will aid practitioners and researchers alike in advancing their knowledge…
Read MoreSystematic review finds more clinical harm than benefits in Alzheimer’s “treatments” lecanemab, aducanumab, and donanemab
Study questions benefit of new Alzheimer’s drug (UGA Today): Last summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer’s. But new research from the University of Georgia suggests that patients and caregivers may not experience any benefit from the drug in their daily lives. The drug, Leqembi,…
Read MoreOn the importance of managing negativity bias to protect cognitive control and prevent depression relapse
Many people around the world suffer from depression. Though depression can be extremely debilitating, evidence-based treatments (like cognitive-behavioral therapy) provide hope, because they can be very effective in treating the negative thinking that accompanies depression.
Read More